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Recent studies have demonstrated that the Ten-eleven
translocation (Tet) family proteins can enzymatically con-
vert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine
(5hmC). While 5mC has been studied extensively, little
is known about the distribution and function of 5hmC.
Here we present a genome-wide profile of 5hmC in
mouse embryonic stem (ES) cells. A combined analysis of
global 5hmC distribution and gene expression profile in
wild-type and Tet1-depleted ES cells suggests that 5hmC
is enriched at both gene bodies of actively transcribed
genes and extended promoter regions of Polycomb-
repressed developmental regulators. Thus, our study
reveals the first genome-wide 5hmC distribution in
pluripotent stem cells, and supports its dual function in
regulating gene expression.
Supplemental material is available for this article.
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Mammalian genomes are chemically modified by DNA
cytosine methylation, an inheritable epigenetic mark
that is implicated in many biological and pathological
processes, including gene regulation, genomic imprint-
ing, X-chromosome inactivation, suppression of trans-
posable elements, and tumorigenesis (Cedar and Bergman
2009; Ooi et al. 2009). Genome-wide studies of mamma-
lian DNA methylation have shown that 5-methylcytosine
(5mC) is widely distributed across the genome in a non-
random manner (Weber et al. 2007; Fouse et al. 2008;
Meissner et al. 2008; Lister et al. 2009). In conjunction
with other epigenetic modifications, 5mC can regulate
accessibility of the DNA to transcription factors and
chromatin regulators, thereby contributing to gene regu-
lation and cellular differentiation.
Recent studies have uncovered 5-hydroxymethylcyto-
sine (5hmC) as the sixth base of the genome, and that the
Ten-eleven translocation (Tet) family proteins is responsi-
ble for the generation of 5hmC from 5mC in mammalian
cells (Kriaucionis and Heintz 2009; Tahiliani et al. 2009;
Ito et al. 2010). This new discovery raises the possibility
that 5hmC may function as another epigenetic mark by
altering chromatin structure or contributing to the re-
cruitment or exclusion of other DNA-binding proteins
that affect transcription. Recent reports have shown that
5hmC is relatively enriched in several cell types, including
mouse embryonic stem (ES) cells and certain neuronal
cells (Kriaucionis and Heintz 2009; Tahiliani et al. 2009;
Globisch et al. 2010; Szwagierczak et al. 2010). Expression
and functional analysis have further demonstrated that
Tet1, the founding member of the Tet family, is highly
expressed in mouse ES cells, and depletion of Tet1 results
in impairment of ES cell self-renewal and maintenance
(Ito et al. 2010). Consistent with the essential role of
Tet1 in ES cells, we showed recently that Tet1 occupies
regulatory regions of both pluripotency-related genes
and Polycomb group (PcG) protein-repressed develop-
mental regulators (Wu et al. 2011). However, little is
known about the genomic distribution of 5hmC, depen-
dence of 5hmC on Tet1 occupancy, and the regulatory
function of 5hmC on transcription. Here we report the
first genome-wide map of 5hmC occupancy in mouse ES
cells. The comparison of 5hmC distribution with other
epigenetic marks and global expression profile provides
evidence for a role of 5hmC in both transcriptional
activation and repression.
Results and Discussion
Genome-wide distribution of 5hmC in mouse ES cells
To test the specificity of 5hmC antibodies in immuno-
precipitating unmethylated, methylated, and hydroxy-
methylated synthetic DNA, we optimized the amount
of input DNA and found that affinity-purified polyclonal
antibodies (Active Motif) for 5hmC specifically immuno-
precipitated 5hmC-containing, but not 5mC- or C-contain-
ing, DNA under denaturing conditions (Supplemental Fig.
S1A). We then tested the ability of both rabbit polyclonal
(Active Motif) and rat monoclonal (Diagenode) antibodies
in immunoprecipitation of genomic DNA at three Tet1-
bound targets (Nanog, Tcl1, and Sox17) determined by
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Tet1 chromatin immunoprecipitation (ChIP) sequencing
(ChIP-seq) (Wu et al. 2011). Quantitative PCR (qPCR)
analysis indicated that both antibodies could readily
immunoprecipitate 5hmC-modified genomic DNA, and
5hmC polyclonal antibodies showed slightly higher im-
munoprecipitation efficiency as compared with the mono-
clonal antibody (Supplemental Fig. S1B,C).
To determine global distribution of 5hmC, we further
tested 5hmC antibody-based immunoprecipitation com-
bined with chromosome-wide tiling microarrays (Supple-
mental Fig. S2A). We found that both antibodies could
consistently detect peaks of 5hmC at defined genomic
regions, and that the 5hmC profile was different from that
of 5mC at both gene and probe levels (Supplemental Fig.
S2A–C), suggesting that the 5hmC antibody is specific.
Since the majority of Tet1-binding sites in mouse ES cells
are within nonrepetitive, gene-rich genomic regions (Wu
et al. 2011), we mapped 5hmC distribution using whole-
genome tiling microarrays that covered the entire non-
repetitive portion of the mouse genome. A total of 91,913
genomic regions enriched with 5hmC were identified
with high confidence (Supplemental Table S1). Nearly
60% of 5hmC peaks were found to be within gene bodies
of annotated RefSeq genes (Fig. 1A), suggesting that
5hmC is also preferentially associated with gene-rich
regions of the genome (Supplemental Fig. 2A). We note
that a recent study profiling the 5hmC distribution in
mouse cerebellum using a different method has come to
a similar conclusion (Song et al. 2011). Further analysis
showed that most 5hmC-enriched regions were associ-
ated with moderate CpG density (Fig. 1B). Thus, 5hmC
antibody-based DNA immunoprecipitation (hMeDIP)
provides a simple and specific tool to investigate the
genomic distribution and function of 5hmC in mamma-
lian cells.
Tet1 is required for maintaining 5hmC levels
at defined genomic regions
We next mapped the 5hmC peaks to all annotated RefSeq
genes in the mouse genome. We found that 5hmC was
preferentially enriched in Tet1-bound genes as compared
with Tet1-unbound genes (Fig. 2A), consistent with the
known enzymatic activity of Tet1. Further analyses of
5hmC peaks within regions flanking transcriptional start
sites (TSSs) of annotated genes indicated that 5hmC
levels were high in genomic regions flanking CpG-rich
proximal promoters and within Tet1-bound CpG-poor
promoters (Supplemental Fig. S3A). Mapping of 5hmC
peaks to Tet1-bound sites also supported the observation
that 5hmC tended to be more enriched in genomic
regions with medium levels of CpG density (Supplemen-
tal Fig. S3B,C). In fact, 5hmC appeared to be excluded
from Tet1-binding sites with high CpG density (Supple-
mental Fig. S3C). The lack of high levels of 5hmC within
these CpG-rich regions may possibly be explained by two
nonmutually exclusive mechanisms: (1) Tet1 is capable of
rapidly hydrolyzing 5mC into 5hmC, which in turn is
converted to unmethylated cytosine by yet-to-be-identi-
fied downstream enzymes within CpG-rich regions. (2)
High levels of trimethylated H3K4 (H3K4me3) within
CpG-rich regions prevent efficient binding of the de novo
DNA methyltransferase complex Dnmt3a2/Dnmt3b/
Dnmt3l in mouse ES cells to these DNA sequences (Ooi
et al. 2007), and thus inhibit accumulation of 5mC
(Supplemental Fig. S3C).
To further investigate the dependence of 5hmC distri-
bution on Tet1 occupancy, we performed lentivirus-
mediated knockdown of Tet1 in mouse ES cells (Ito
et al. 2010). The results shown in Figure 2B demonstrate
that knockdown of Tet1 resulted in reduced 5hmC levels
at Tet1 regions throughout the genome that include Tet1-
bound promoters, gene bodies, and intergenic regions.
Many Tet1-binding sites, particularly those at CpG-rich
proximal promoters, did not show a decrease in 5hmC
level in the absence of Tet1 proteins (Fig. 2B,C; Supple-
mental Fig. S4A,B). This is likely due to a lack of 5hmC
enrichment at these sites in wild-type mouse ES cells (Fig.
2C; Supplemental Fig. S3C). However, an increase in
5mC levels was still frequently observed within both
promoter and nonpromoter Tet1-binding sites (Fig. 2B–D;
Supplemental Fig. S4A), indicating that Tet1 has a role in
maintaining a DNA hypomethylated state at these sites.
Taken together, these results indicate that Tet1 is re-
quired for establishing a defined genomic pattern of
5hmC, and also for initiating an enzymatic cascade to
maintain CpG-rich gene promoters in a DNA hypo-
methylated state.
5hmC is enriched in both Tet1-activated
and Tet1-repressed genes
Previous genome-wide analyses have shown that distri-
bution of DNA methylation in the genome may also be
regulated by histone modifications (Ooi et al. 2007;
Schlesinger et al. 2007; Mohn et al. 2008). For example,
H3K4me3 at proximal promoters generally regulates
Figure 1. Genomic distribution of 5hmC in mouse ES cells. (A)
Genomic distribution of 5hmC-enriched regions ([log10 peak
P-value] > 2.3) relative to University of California at San Diego
RefSeq genes (NCBI build 36). The genome-wide 5hmC occupancy
was determined by whole-genome tiling microarray analysis. (B)
Proportion of 5hmC-enriched regions with different CpG densities.
Note that 5hmC is enriched at genomic regions with moderate-
density CpG dinucleotides.
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DNA methylation levels in a negative fashion (Weber
et al. 2007; Meissner et al. 2008), whereas H3K36me3
within actively transcribed gene bodies is positively
correlated with the presence of high levels of DNA
methylation (Ball et al. 2009). To further investigate the
relationship between Tet1, 5hmC, and major histone
modifications at Tet1-bound genes, we cross-referenced
the 5hmC profile with published genome-
wide occupancy of major histone modifica-
tions. As Tet1 can bind to both actively
transcribed genes and Polycomb repression
complex 2 (PRC2)-repressed developmen-
tal regulators (positive for Ezh2 and
H3K27me3) (Wu et al. 2011), we analyzed
these two groups of Tet1-bound genes sepa-
rately (Fig. 3A). This analysis revealed that
5hmC was relatively more enriched at in-
tragenic regions (Fig. 3B,C), particularly at the
39 end of the gene body for actively tran-
scribed Tet1-only targets (e.g., Rest in Fig.
3C), similar to the transcription elongation
mark H3K36me3 (Mikkelsen et al. 2007). In
contrast, enrichment of 5hmC was more
prominent at extended promoter regions—
including both upstream of and downstream
from TSSs (Fig. 3B,C)—of Tet1/PRC2-
cobound targets (e.g., Lhx2 in Fig. 3C). Thus,
5hmC enrichment at Tet1-bound genes may
contribute to maintenance of both the tran-
scriptionally active and inactive chromatin
states by functionally interacting with dis-
tinct histone modifications and their associ-
ated proteins.
Relationship between 5hmC distribution
and chromatin occupancy of
pluripotency-related transcription factors
and other genomic features
The fact that DNA methylation can affect
the binding of many DNA-binding proteins
to their target sequences raises the possi-
bility that 5hmC may also be involved in
regulating the protein–DNA interactions.
To investigate this potential relationship in
mouse ES cells, we mapped 5hmC micro-
array signals to previously determined bind-
ing sites of a set of proteins important for
pluripotency (e.g., Nanog, Sox2, and Oct4)
(Chen et al. 2008). In contrast to a general
depletion of 5mC at DNA–protein interac-
tion sites, we observed a relative enrich-
ment of 5hmC toward the site of most
DNA-binding proteins (Supplemental Fig.
S5). Previous analysis of DNA methylation
in human ES cells using whole-genome bi-
sulfite sequencing suggests that 5mC in
a non-CpG context, but not CpG DNA
methylation, is greatly depleted from bind-
ing sites of transcription factors related to
pluripotency (Lister et al. 2009). Since bi-
sulfite treatment cannot discriminate 5mC
from 5hmC (Huang et al. 2010; Jin et al.
2010), bisulfite sequencing may overesti-
mate the 5mC levels at these binding sites.
Indeed, specific antibody-based immunoprecipitation
analysis of 5mC and 5hmC in mouse ES cells indicated
that 5mC was generally depleted from DNA–protein
interaction sites, whereas 5hmC was relatively enriched
at these sites (Supplemental Fig. S5).
We next analyzed a set of genomic features defined by
histone modifications or sequence-specific DNA-binding
Figure 2. Tet1 is required for maintaining 5hmC levels at defined genomic regions in
ES cells. (A) Distribution of 5hmC relative to all annotated genes in ES cells. Averaged
5hmC enrichment (measured by log10 peak P-value) in 200-base-pair (bp) bins
upstream of/downstream from gene bodies or at 5% intervals within the gene body is
shown along the transcription units from 5 kb upstream of TSSs to 5 kb downstream
from the transcriptional end sites (TESs). Note that 5hmC levels are generally enriched
in Tet1-bound genes as compared with Tet1-unbound genes. (B) Changes in 5hmC and
5mC enrichment (measured by log10 peak P-value) in response to Tet1 knockdown are
shown for Tet1-bound regions associated with different genomic features (gene body,
intergenic region, and promoter [2 kb flanking TSSs]). (C) Heat map representation of
CpG islands and occupancy of Tet1, 5mC, and 5hmC in mouse ES cells at all Tet1-
enriched regions (5 kb flanking the center of Tet1 peaks). The heat map is rank-ordered
by CpG density of genomic regions within 500 bp flanking the center of Tet1 peaks. The
enrichment of 5hmC and 5mC was determined by whole-genome tiling microarrays. Tet1-
bound regions at gene bodies, promoters, and intergenic regions are shown separately. The
enrichment of Tet1 binding was determined previously by ChIP-seq analyses (Wu et al.
2011). All average binding was measured by log10 (peak P-values) in 200-bp bins and are
shown by color scale. The following color scales (white, no enrichment; blue, high
enrichment) are used for 5hmC, 5mC, and Tet1, respectively: [0, 2], [0, 0.5], and [0, 50]. The
presence of CpG islands is displayed in color (blue, present; white, absent). (D) Tet1
occupancy and changes in 5hmC/5mC levels are shown for a group of representative Tet1
targets (Pcdha gene cluster on chr18) in control (Con) and Tet1 knockdown (Tet1 KD) ES
cells. Tet1 ChIP-seq data in control knockdown (Con KD) and Tet1 knockdown (Tet1 KD)
are shown in read counts, with the Y-axis floor set to 0.2 read per million reads. 5hmC and
5mC levels are shown as log2 ratios of immunoprecipitation/input (IP/input).
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proteins, including H3K4me3-enriched promoter regions,
methylated H3K4 (H3K4me1)-enriched enhancers, Ctcf-
marked insulators, and H3K36me3-enriched transcribed
intragenic regions (Mikkelsen et al. 2007; Chen et al.
2008; Meissner et al. 2008). Except for H3K36me3-
enriched regions, 5mC was, in general, depleted from
these genomic features (Supplemental Fig.
S5), consistent with the notion that DNA
methylation negatively regulates most
DNA–protein interactions. In contrast, av-
erage signal profiles of 5hmC showed a rela-
tive enrichment at promoters, enhancers,
transcribed regions, and insulators (Supple-
mental Fig. S5). Notably, the general enrich-
ment of 5hmC at H3K4me3 peaks indicates
that the absence of 5hmC at a subset of
CpG-rich, H3K4me3-enriched proximal pro-
moters is probably due to the existence of
additional regulatory factors of Tet1 activity
or proteins capable of rapidly converting
5hmC into unmethylated cytosine at these
sites. Furthermore, the observed enrichment
of 5hmC and concomitant depletion of 5mC
at enhancer or insulator sequences may
therefore contribute to maintaining a more
accessible chromatin structure for binding of
enhancer proteins (e.g., p300) and Ctcf to
these sites. Enrichment of both 5hmC and
5mC at actively transcribed regions marked
by high levels of H3K36me3 suggests a tran-
scriptional link between these two marks
(Supplemental Fig. S5).
5hmC has different distribution profiles
at active and repressed genes
To investigate a potential role of 5hmC in
transcriptional regulation, we examined the
relationship between 5hmC distribution
and the global gene expression profile. This
analysis showed that 5hmC was relatively
enriched within intragenic regions of genes
transcribed at high and medium levels (Fig.
4A, blue and red; Supplemental Fig. S6, blue
and red), as well as promoter regions of
transcriptionally inactive genes (Fig. 4A,
green; Supplemental Fig. S6, green). Further
analysis of 5hmC distribution on Tet1-
bound genes ranked by their expression
levels also supported a potential role of
5hmC in both transcriptional activation
and repression (Fig. 4B). Interestingly,
5hmC was enriched at promoters of both
Tet1/PRC2-cobound (Supplemental Fig. S7,
blue) and Tet1-only targets that were
expressed at low levels (Supplemental Fig.
S7, purple) in mouse ES cells, suggesting
that promoter 5hmC may function as a gen-
eral repressive mark (Supplemental Fig. S7).
To investigate further how 5hmC distribu-
tion may contribute to Tet1-dependent gene
expression, we compared the 5hmC profiles
between control and Tet1-depleted ES cells
on Tet1-repressed and Tet1-activated tar-
gets. We found that 5hmC levels were de-
creased at both groups of Tet1 targets (Sup-
plemental Fig. S8). A decrease in 5hmC was more
pronounced at promoter regions and the 59 end of in-
tragenic regions on Tet1-repressed targets, whereas a de-
pletion of intragenic 5hmC was evident for Tet1-acti-
vated targets. Taken together, these results indicate that,
similar to 5mC, 5hmC may play a complex role in
Figure 3. 5hmC is enriched in both repressed (bivalent, Tet1/PRC2-cobound) and
actively transcribed (Tet1-only) genes. (A) Heat map representation of genomic regions
with enriched 5hmC, binding profile of Tet1 and Ezh2, and major histone modifications
(H3K4me3, H3K27me3, and H3K36me3) (Mikkelsen et al. 2007) in mouse ES cells at all
Tet1 target genes (5 kb flanking TSSs). The heat map is rank-ordered from genes with
the highest H3K27me3 enrichment to no H3K27me3 within 5-kb genomic regions
flanking TSSs. The enrichment of 5hmC and 5mC was determined by whole-genome
tiling microarrays. The enrichment of Tet1, H3K4me3, H3K27me3, and H3K36me3
binding was determined previously by ChIP-seq analyses (Mikkelsen et al. 2007; Wu
et al. 2011). All average binding was measured by log10 (peak P-values) in 200-bp bins
and is shown by color scale. The following color scales (white, no enrichment; blue, high
enrichment) are used for 5hmC/5mC, Tet1/H3K27me3/H3K36me3, and H3K4me3, re-
spectively: [0, 2], [0, 50], and [0, 100]. The presence of CpG islands is displayed in color (blue,
present; white, absent). (B) Average distribution profiles of 5hmC enrichment are shown for
Tet1/PRC2-cobound targets, Tet1-only targets, and nontargets. Averaged expression levels
of these three groups of genes are shown in the bottom panels (measured by log2 values of
expression microarray signals). (C) Shown are profiles of Tet1 (Wu et al. 2011), 5hmC, Ezh2
(Ku et al. 2008), RNA polymerase II (Seila et al. 2008), and major histone modification
(Mikkelsen et al. 2007) occupancy at two representative Tet1 targets: a Tet1/PRC2-
cobound target (Lhx2), and a Tet1-only target (Rest promoter). ChIP-seq data in mouse
ES cells are shown in read counts, with the Y-axis floor set to 0.2 read per million reads.
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transcriptional regulation, depending on its location (Wu
et al. 2010). Our analysis of 5hmC distribution in mouse
ES cells suggests that promoter and gene body 5hmC may
preferentially contribute to gene repression and activa-
tion, respectively.
In summary, our studies have presented a genome-wide
map of 5hmC in mouse ES cells. Systematic comparison
of 5hmC distribution, Tet1 occupancy, and major histone
modifications indicate that 5hmC may be involved in
establishing and maintaining chromatin structure for both
actively transcribed genes and PcG-repressed developmen-
tal regulators. We also provide initial evidence indicating
that 5hmC may contribute to both transcriptional activa-
tion and repression in a context-dependent manner. Collec-
tively, these results and the demonstration of a simple
antibody-based approach in genome-wide 5hmC mapping
have set the stage for further understanding the functions of
Tet family proteins and 5hmC in development and disease.
Materials and methods
Genome-wide and locus-specific 5hmC analysis (hMeDIP)
To immunoprecipitate 5hmC, genomic DNA was sequentially digested
with proteinase K and RNase A and purified by phenol-chloroform
extraction. Purified genomic DNA was sonicated to 200–1000 base pairs
(bp) and heat-denatured (10 min, 95°C). An aliquot of
sonicated genomic DNA was saved as input. Five micro-
grams of fragmented genomic DNA was immunoprecip-
itated with 5 mg of rat 5hmC Ab (Diagenode, catalog no.
MAb-633HMC) or rabbit 5hmC Ab (Active Motif, cata-
log no. 39791) overnight at 4°C in a final volume of 500
mL of immunoprecipitation buffer (10 mM sodium phos-
phate at pH 7.0, 140 mM NaCl, 0.05% Triton X-100). The
DNA–antibody mixture was incubated with 30 mL of
protein G Dynabeads (Invitrogen) for 2 h at 4°C and
washed three times with 1 mL of immunoprecipitation
buffer. The beads were then treated with proteinase K for
at least 3 h at 55°C, and the methylated DNA was
purified by phenol-chloroform extraction followed by
ethanol precipitation. For whole-genome DNA tiling
microarray analysis, immunoprecipitated 5hmC-con-
taining DNA from control or Tet1-depleted ES cells
was cohybridized with input DNA to mouse whole-
genome tiling microarrays (NimbleGen). Locus-specific
hMeDIP–qPCR was performed similarly using nondena-
tured genomic DNA, and immunoprecipitated DNA was
analyzed on an ABI 7300 system (Applied Biosystems)
using SYBR Green (Invitrogen). Primer sequences are
listed in Supplemental Table S2.
To evaluate the immunoprecipitation efficiency of
5hmC antibodies (Active Motif) for synthetic DNA
(949 bp; Zimo Research), 25 pg of unmethylated, meth-
ylated, or hydroxymethylated DNA was diluted in 480
mL of 13 TE buffer. DNA was heat-denatured for 10 min
at 95°C, and chilled for 5 min on ice. 5hmC immuno-
precipitation was performed as described above. qPCR
was carried out with primers H/me-1-F (AGGTGGAGG
AAGGTGATGTC) and H/me-1-R (ATAAACCGAACC
GCTACACC).
Whole-genome tiling microarray analysis
For whole-genome DNA tiling microarray analysis of
5hmC distribution, immunoprecipitated and input DNA
was prepared from both control and Tet1-depleted ES
cells and amplified using a whole-genome amplification
kit (Sigma). Probe labeling, amplification, hydridization,
data extraction, and analysis were performed as de-
scribed previously (Wu et al. 2011).
For identification of probes associated with significant levels of 5hmC,
a nonparametric one-sided Kolmogorov-Smirno (KS) test was used. Briefly,
from the scaled log2 ratio data, a fixed-length window (750 bp) was placed
around each consecutive probe, and the one-sided KS test was applied to
determine whether the probes were drawn from a significantly more
positive distribution of intensity log ratios than those in the rest of the
array. The resulting score for each probe was the [log10 P-value] from the
windowed KS test around that probe. Peak data files were generated from
the P-value data files using NimbleScan version 2.5. Peaks within 500 bp
of each other were merged. For calculating the absolute 5mC levels in
control knockdown and Tet1 knoockdown ES cells, the MEDME program
(Pelizzola et al. 2008) was used to correct the nonlinear relationship between
microarray signals and genomic CpG density. To visualize 5mC and 5hmC
distributions in the Cisgenome browser (Ji et al. 2008), probe-level smoothing
(log2 ratios of probes within 1 kb are averaged) was performed for each probe.
To calculate the peak distribution, averaged 5hmC or 5mC enrichment
(measured by [log10 peak P-value]) was binned to 200-bp intervals within
genomic regions 5 kb upstream of and downstream from TSSs or transcrip-
tional end sites (TESs) of annotated RefSeq genes. Heat maps were generated
and visualized using Cluster3 and Java Treeview, respectively. 5mC and
5hmC whole-genome tiling microarray data have been deposited in the
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under
accession number GSE26833 (Wu et al. 2011) and GSE27613, respectively.
Constructs and antibodies
All of the constructs and antibodies used in this study were described
previously (Ito et al. 2010; Wu et al. 2011).
Figure 4. Relationship between 5hmC enrichment and gene expression in mouse ES
cells. (A) Distribution of 5hmC, 5mC, and RNA polymerase II at genes expressed at
different levels in ES cells. Enrichment of 5hmC and 5mC was measured by raw log2
ratios of immunoprecipitation/input (IP/input) and MEDME-corrected values of log2
ratios, respectively. (B) Heat map representation of genomic regions with enriched
5hmC, binding profile of Tet1 and Ezh2, and major histone modifications in mouse ES
cells at all Tet1 target genes (5 kb flanking TSSs). The heat map is rank-ordered by gene
expression levels of Tet1-bound genes. All average binding was measured by log10 (peak
P-values) in 200-bp bins and is shown by color scale. The following color scales (white, no
enrichemnt; blue, high enrichment) are used for 5hmC, Tet1/Ezh2/H3K27me3/
H3K36me3, and H3K4me3, respectively: [0, 2], [0, 50], and [0, 100].
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ChIP-seq, gene expression profiling, and data analysis
ChIP-seq experiments and data analysis for Tet1 were described previously
(Wu et al. 2011). ChIP-seq data sets of H3K4me3, H3K27me3, H3K36me3
(Mikkelsen et al. 2007), Ezh2 (Ku et al. 2008), and RNA polymerase II (Seila
et al. 2008) were obtained from previous publications and reanalyzed in
MACS using identical parameters (except statistical cutoff was set to
P-value < 105). ChIP-seq sequencing read counts for each ChIP-seq experi-
ments were binned into 400-bp windows at 100-bp steps along the genome
and visualized in the Cisgenome browser (Ji et al. 2008). To assign ChIP-seq
enriched regions to genes, RefSeq genes were downloaded from the UCSC
Table Browser (May 2010). For all data sets, genes with enriched regions
within 5 kb of their TSSs were called bound. Gene expression profiling
analysis of control and Tet1-depleted mouse ES cells was carried out using
the Affymetrix GeneChip Mouse Genome 430 2.0 array. Tet1 ChIP-seq and
gene expression microarray data have been deposited in the Gene Expres-
sion Omnibus under accession number GSE26833 (Wu et al. 2011).
Mouse ES cell culture, Tet knockdown, and qPCR
Mouse E14Tg2A ES cells were cultured in feeder-free conditions (Ito et al.
2010). Control and Tet1 knockdown cell preparation and qPCR verifica-
tion were described previously (Wu et al. 2011).
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